IS
Ibrahim Saud Said Al Zakwani
Director Nominee Director DIN 09608423
Unlock full profile Investments · shareholding · contact details
Past companies 1 historical roles
Total affiliations 1 Since May 2022
Shareholding value •••• Premium profile
About Ibrahim Saud Said Al Zakwani
Data last updated:
Ibrahim Saud Said Al Zakwani was a Nominee Director at Biogenomics Limited (2022–2024). The company operates in Pharma.
DIN 09608423
Primary Designation Nominee Director
Industry Pharma
First Appointment 31 May 2022
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Biogenomics Limited U24234PY2002PLC009158 | Nominee Director | 31 May 2022 | 2002 | ₹13.42 Cr (FY 2024) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Biogenomics Limited
Premium access
Shareholding and investment profile for Ibrahim Saud Said Al Zakwani
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ibrahim Saud Said Al Zakwani
Ibrahim Saud Said Al Zakwani was first appointed on 31 May 2022 as Nominee Director at Biogenomics Limited.
Ibrahim Saud Said Al Zakwani held 1 earlier board appointment: Biogenomics Limited (Nominee Director, 31 May 2022 to 11 Aug 2024).